<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-08-29">29 August 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Pia</forename><surname>Riemke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Molecular Tumor Biology</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Melinda</forename><surname>Czeh</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Molecular Tumor Biology</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Josephine</forename><surname>Fischer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Molecular Tumor Biology</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carolin</forename><surname>Walter</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical Informatics</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Saeed</forename><surname>Ghani</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Hematology, Oncology, and Tumor Immunology</orgName>
								<orgName type="institution">Robert-Rössle-Clinic</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Zepper</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Molecular Tumor Biology</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Konstantin</forename><surname>Agelopoulos</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Dermatology</orgName>
								<orgName type="department" key="dep2">Competence Center Chronic Pruritus</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><surname>Lettermann</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Molecular Hematology and Oncology</orgName>
								<orgName type="department" key="dep2">Medical Clinics A</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marie</forename><forename type="middle">L</forename><surname>Gebhardt</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Computational Biology and Data Mining</orgName>
								<orgName type="department" key="dep2">Max-Delbrück-Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nancy</forename><surname>Mah</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Berlin-Brandenburger Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andre</forename><surname>Weilemann</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Translational Oncology</orgName>
								<orgName type="department" key="dep2">Medical Clinics A</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Cluster of Excellence EXC 1003</orgName>
								<orgName type="department" key="dep2">Cells in Motion</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Grau</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Translational Oncology</orgName>
								<orgName type="department" key="dep2">Medical Clinics A</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Cluster of Excellence EXC 1003</orgName>
								<orgName type="department" key="dep2">Cells in Motion</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Verena</forename><surname>Gröning</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Molecular Tumor Biology</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Torsten</forename><surname>Haferlach</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution">MLL Munich Leukemia Laboratory</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dido</forename><surname>Lenze</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ruud</forename><surname>Delwel</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Department of Hematology</orgName>
								<orgName type="institution">Erasmus University Medical Center</orgName>
								<address>
									<settlement>Rotterdam</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Prinz</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Institute of Neuropathology</orgName>
								<orgName type="institution">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">BIOSS Centre for Biological Signalling Studies</orgName>
								<orgName type="institution">University of Freiburg</orgName>
								<address>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Miguel</forename><forename type="middle">A</forename><surname>Andrade-Navarro</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Medical Informatics and Biomathematics</orgName>
								<orgName type="department" key="dep2">Institute of Molecular Biology</orgName>
								<orgName type="institution">Johannes Gutenberg University of Mainz</orgName>
								<address>
									<settlement>Mainz</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Lenz</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Translational Oncology</orgName>
								<orgName type="department" key="dep2">Medical Clinics A</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Cluster of Excellence EXC 1003</orgName>
								<orgName type="department" key="dep2">Cells in Motion</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Dugas</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Medical Informatics</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Müller-Tidow</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Internal Medicine, Hematology and Oncology</orgName>
								<orgName type="institution">University of Halle-Wittenberg</orgName>
								<address>
									<settlement>Halle</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Frank</forename><surname>Rosenbauer</surname></persName>
							<email>frank.rosenbauer@ukmuenster.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Molecular Tumor Biology</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Bullinger</surname></persName>
						</author>
						<title level="a" type="main">Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-08-29">29 August 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">95895AEBDCF3477C377A6AD2EA8EBAEF</idno>
					<idno type="DOI">10.15252/embj.201693927</idno>
					<note type="submission">Received 21 January 2016 | Revised 25 July 2016 | Accepted 27 July 2016 |</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>leukemia</term>
					<term>lineage plasticity</term>
					<term>myeloid differentiation</term>
					<term>T-cell progenitors Subject Categories Cancer</term>
					<term>Development &amp; Differentiation</term>
					<term>Immunology</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Unfavorable patient survival coincides with lineage plasticity observed in human acute leukemias.</s><s>These cases are assumed to arise from hematopoietic stem cells, which have stable multipotent differentiation potential.</s><s>However, here we report that plasticity in leukemia can result from instable lineage identity states inherited from differentiating progenitor cells.</s><s>Using mice with enhanced c-Myc expression, we show, at the single-cell level, that T-lymphoid progenitors retain broad malignant lineage potential with a high capacity to differentiate into myeloid leukemia.</s><s>These T-cell-derived myeloid blasts retain expression of a defined set of T-cell transcription factors, creating a lymphoid epigenetic memory that confers growth and propagates myeloid/T-lymphoid plasticity.</s><s>Based on these characteristics, we identified a correlating human leukemia cohort and revealed targeting of Jak2/Stat3 signaling as a therapeutic possibility.</s><s>Collectively, our study suggests the thymus as a source for myeloid leukemia and proposes leukemic plasticity as a driving mechanism.</s><s>Moreover, our results reveal a pathway-directed therapy option against thymus-derived myeloid leukemogenesis and propose a model in which dynamic progenitor differentiation states shape unique neoplastic identities and therapy responses.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Acute leukemia (AL) refers to a heterogeneous group of blood cell disorders in which differentiation-blocked malignant myeloid or lymphoid cells expand uncontrolled.</s><s>The treatment for AL depends on how the disease is classified according to both cytogenetic and phenotypic markers <ref type="bibr" target="#b1">(Bene et al, 1995;</ref><ref type="bibr" target="#b15">Dohner et al, 2010)</ref>.</s><s>However, up to 20% of ALs remain difficult to classify, as they express both lymphoid and myeloid antigens <ref type="bibr" target="#b45">(Matutes et al, 1997;</ref><ref type="bibr" target="#b27">Golemovic et al, 2006)</ref>.</s><s>Clinically, these "ambiguous" AL cases are highly relevant because they result in particularly poor patient survival and are frequently resistant to standard therapies <ref type="bibr" target="#b27">(Golemovic et al, 2006;</ref><ref type="bibr" target="#b12">Coustan-Smith et al, 2009;</ref><ref type="bibr" target="#b16">Dorantes-Acosta &amp; Pelayo, 2012)</ref>.</s><s>In addition to lineage marker ambiguity, ALs that switch lineages in treatment-associated relapse have been described <ref type="bibr" target="#b69">(Stass et al, 1984;</ref><ref type="bibr" target="#b57">Risueno et al, 2011)</ref>.</s><s>These findings imply that hematopoietic malignancies can hold immanent potential to differentiate into alternative lineages.</s><s>While earlier studies have assumed that leukemias with lineage infidelity and switching capacity can arise upon malignant transformation of a hematopoietic stem cell (HSC; <ref type="bibr" target="#b45">Matutes et al, 1997;</ref><ref type="bibr">Neumann et al, 2012)</ref>, the underlying cellular origin of such lineage plasticity remains poorly defined.</s></p><p><s>One type of AL, acute myeloid leukemia (AML), is believed to originate from transformed HSCs or myeloid-restricted progenitors <ref type="bibr" target="#b78">(Walter et al, 2012)</ref>.</s><s>However, these bone marrow (BM)-resident precursors are not the only cells with myeloid potential: myeloid potential has also been found in thymic CD4/CD8 double negative 1 (DN1) and 2 (DN2) cells, which represent the earliest stages of T-cell development <ref type="bibr" target="#b0">(Bell &amp; Bhandoola, 2008;</ref><ref type="bibr" target="#b77">Wada et al, 2008)</ref>.</s><s>However, the contribution of DN1 and DN2 cells to physiological myelopoiesis in vivo has been questioned by lineage-tracing experiments <ref type="bibr" target="#b65">(Schlenner et al, 2010)</ref>.</s><s>Nevertheless, the same authors found that approximately 15% of DN1 cells had robust myeloid differentiation capacity in vitro, confirming that thymic progenitors can produce myeloid progeny <ref type="bibr" target="#b65">(Schlenner et al, 2010)</ref>.</s><s>In another study, myeloid potential was attributed to thymic progenitors in vivo, and early T cells were suggested as precursors of thymic granulocytes <ref type="bibr" target="#b13">(De Obaldia et al, 2013)</ref>.</s><s>However, even if a contribution to myelopoiesis under homeostatic conditions is still unclear, these results demonstrated that the lymphoid fate of early T-cell progenitors is not yet fully stabilized and may compete with a residual option of myeloid differentiation.</s><s>Therefore, we hypothesized that this myeloid potential may be exploited under pathological conditions so that T-cell precursors could transdifferentiate into leukemia with myeloid identity.</s></p><p><s>To test this hypothesis, we aimed to analyze the lineage potential of DN2 cells upon transformation.</s><s>We reasoned that ectopic c-Myc (Myc) expression would serve our purpose best, as MYC has been demonstrated to transform cells, at least in part, by amplifying the expression of already transcribed genes without enforcing a lineage bias <ref type="bibr" target="#b41">(Lin et al, 2012;</ref><ref type="bibr" target="#b52">Nie et al, 2012)</ref>.</s><s>Moreover, MYC is frequently overexpressed in both human acute myeloid and lymphoid leukemia <ref type="bibr" target="#b44">(Majeti et al, 2009;</ref><ref type="bibr" target="#b30">Haferlach et al, 2010)</ref>  <ref type="bibr">(Appendix Fig S1A)</ref> and can rapidly induce hematopoietic neoplasias in mice <ref type="bibr" target="#b43">(Luo et al, 2005)</ref>.</s><s>We therefore overexpressed Myc, together with Bcl2 to prevent apoptosis, in murine thymic and BM-resident precursor cells and compared their lineage potential in leukemogenesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Single DN2 cells possess malignant myeloid and T-lymphoid potential in vitro</head><p><s>To evaluate the lineage potential of transformed T-cell precursors, we isolated DN2 cells from the thymus along with BM LSK cells (Lineage À Sca1 + c-kit + as a population enriched for HSCs) and granulocytemacrophage progenitors (GMPs) from C57BL/6 CD45.2 donor wildtype mice.</s><s>Cells were transduced with a retrovirus co-expressing Myc and Bcl2 from a bicistronic mRNA (Myc/Bcl2) .</s><s>From these populations, we sorted single cells into 96-well plates containing 1:1 mixtures of OP9:OP9-DL1 as feeder cell layers and analyzed the resulting clones via flow cytometry for the expression of CD11b and Gr1 as myeloid markers, and CD25 as an early T-lineage marker which was in line with previous reports <ref type="bibr" target="#b0">(Bell &amp; Bhandoola, 2008;</ref><ref type="bibr" target="#b77">Wada et al, 2008)</ref>.</s><s>Myc/Bcl2-transduced DN2 cells generated immortalized clones with 8.6% plating efficiency, all of which had either mixed myeloid/T-cell or pure T-cell phenotypes <ref type="bibr">(Fig 1A and B)</ref>.</s><s>From the mixed-lineage clones, flow-sorted myeloid cells or lymphoid cells demonstrated typical blast-like myeloid or lymphoid morphologies, respectively, and produced short-latency leukemias in transplanted mice, indicating their fully transformed states <ref type="bibr">(Fig 1C)</ref>.</s><s>In contrast to DN2 cells, single Myc/Bcl2 + GMPs produced exclusively myeloid clones, and single Myc/Bcl2 + LSK cells produced predominantly pure myeloid clones but also mixed myeloid/T-cell and pure T-cell clones at lower frequencies <ref type="bibr">(Fig 1B and D)</ref>.</s><s>These results show that at the single-cell level, transformed DN2 cells do not exclusively produce T-lymphoid leukemia, but can also develop into myeloid leukemia.</s></p><p><s>The myeloid potential of DN2 cells was stable across the leukemia transforming event, as transduction with the MLL-AF9 [t(9;11)] oncogenic fusion also generated mixed myeloid/T-cell clones at high frequency <ref type="bibr">(Appendix Fig S2A and B)</ref>.</s><s>This suggests that the potential to produce myeloid blasts represents a feature that is endogenous to transformed DN2 cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DN2 cells with T-cell receptor rearrangement can generate myeloid leukemic progeny</head><p><s>The defining step in T-cell development is rearrangement of the T-cell receptor (TCR) locus.</s><s>Thus, to underscore that T-cell progenitors can transform into myeloid blasts, we first identified rearrangement of the TCR beta locus in Myc/Bcl2 + DN2-and DN1-derived myeloid clones <ref type="bibr">(Appendix Fig S2C)</ref> and subsequently transplanted one of each into mice.</s><s>In both cases, the donor cells rapidly produced lethal myeloid leukemias, in which the blasts carried the same rearrangements as the initial clones <ref type="bibr">(Fig 1E and F and data not shown)</ref>.</s><s>This experiment provides genetic evidence that myeloid leukemia can originate from T-cell progenitors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transformed DN2 cells give rise to leukemias with clonal myeloid and T-lymphoid populations in vivo</head><p><s>To directly assess the leukemic lineage potential in vivo, we first transduced DN2 cells with Myc/Bcl2 and then immediately transplanted them intravenously into sublethally irradiated congenic mice.</s><s>In line with the in vitro results, Myc/Bcl2 + DN2 cells produced leukemias consisting of myeloid, T-cell, and biphenotypic fractions in the same recipients <ref type="bibr">(Fig 2A)</ref>.</s><s>We also did this for Myc/Bcl2 + LSK cells, which also produced mixed-lineage leukemia, but with reduced T-lymphoid and biphenotypic fractions.</s><s>The Myc/Bcl2 + GMPs exclusively produced myeloid leukemia.</s><s>We also generated Myc/Bcl2 + DN3 cells, representing a more differentiated T-cell progenitor, which produced exclusively T-lymphoid leukemia, in part with dim co-expression of myeloid markers, but never myeloid leukemia <ref type="bibr">(Appendix Fig S3A)</ref>.</s></p><p><s>The mean survival of Myc/Bcl2+ DN2, LSK and GMP recipients was comparably short ( <ref type="formula">56</ref>  To exclude the possibility that the short-term cultivation required for retroviral transduction imposed a myeloid lineage bias on DN2 cells, we showed that the in vivo differentiation capacity of mock virus-transduced cells was similar to that of DN2 cells freshly isolated from the thymus <ref type="bibr">(Fig 2G;</ref><ref type="bibr" target="#b56">Richie Ehrlich et al, 2011)</ref>.</s><s>Moreover, to more closely model the physiological transformation process in vivo, we also transplanted Myc/Bcl2 + DN2 cells directly into the thymus, and confirmed their myeloid leukemic potential <ref type="bibr">(Fig 2F)</ref>.</s><s>Intrathymic Myc/Bcl2 + DN2-or GMP-grafts developed fullblown leukemia after 36 AE 2 and 46 AE 5 days, respectively <ref type="bibr">(Appendix Fig S3G)</ref>.</s></p><p><s>When comparing cell engraftment in BM, spleen, and thymus, we found that DN2-and GMP-derived blasts disseminated differently.</s><s>Myc/Bcl2 + cells from GMPs preferentially infiltrated the organ(s) associated with their site of transplantation.</s><s>Intravenously transplanted GMP-derived blasts primarily infiltrated the BM and spleen rather than the thymus <ref type="bibr">(Appendix Fig S3H)</ref>, while intrathymically transplanted GMP-derived blasts mainly stayed within the thymus.</s><s>In contrast, Myc/Bcl2 + DN2-derived blasts infiltrated equally into all organs, suggesting an enhanced dissemination capacity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DN2-myeloid blasts have DC-like identity and retain a cell-oforigin memory</head><p><s>To determine the molecular mechanisms that drive development of myeloid blasts from DN2 cells, we performed gene expression profiling of flow-sorted myeloid fractions of Myc/Bcl2 + DN2-, LSK-and GMP-derived leukemias from sick mice, along with normal DN2 und GMP cells from healthy wild-type (WT) mice (Dataset EV1).</s><s>To better disclose the lineage identity of the diseased cells, we used gene set enrichment analysis (GSEA) to compare transcriptomes of the flow-sorted myeloid fractions to gene signatures defining different myeloid cell populations <ref type="bibr" target="#b66">(Schonheit et al, 2013)</ref>.</s><s>Whereas the GMP-and LSK-derived myeloid blasts mainly demonstrated a neutrophil identity, DN2-derived myeloid blasts exhibited a pandendritic cell (DC) signature <ref type="bibr">(Fig 3A)</ref>, a finding confirmed with another DC signature <ref type="bibr" target="#b7">(Chan et al, 2006;</ref><ref type="bibr">data not shown)</ref>.</s><s>This was in line with residual DC potential that has been assigned to early T-cell progenitors <ref type="bibr" target="#b48">(Moore et al, 2012)</ref>.</s></p><p><s>Through a heat map comparison of the top 100 genes most differentially expressed (P ≤ 0.05) in each of the analyzed cell populations, we revealed that DN2-and GMP-derived myeloid blasts clearly differed from each other, but LSK-derived blasts had an intermediate phenotype <ref type="bibr">(Fig 3B and Dataset EV2</ref>).</s><s>Yet, unsupervised hierarchical clustering across the entire transcriptomes revealed that LSK-and GMP-derived cells are more closely related to each other than they are to DN2-derived cells <ref type="bibr">(Fig 3C)</ref>.</s><s>Moreover, GSEA demonstrated that a signature of genes highly expressed in WT DN2 cells was significantly enriched in the DN2-but not in GMP-or LSK-derived myeloid blasts <ref type="bibr">(Fig 3D and Dataset EV3)</ref>.</s><s>Collectively, gene expression profiling revealed that DN2-leukemia adopts a unique myeloid lineage identity, and still retains expression of a memory of its pre-malignant T-cell origin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The T-cell memory is required for DN2-leukemia growth</head><p><s>We next assessed if the T-cell memory was involved in driving Myc/ Bcl2 + DN2-leukemia.</s><s>Because cell-specific gene programs are mainly regulated by transcription factors <ref type="bibr" target="#b60">(Rosenbauer &amp; Tenen, 2007;</ref><ref type="bibr" target="#b61">Rothenberg et al, 2008)</ref>, we searched for genes in the thymic memory that encode transcription factors and identified Bcl11b and Gata3 as two promising candidates <ref type="bibr" target="#b64">(Sambandam et al, 2005;</ref><ref type="bibr" target="#b62">Rothenberg, 2012)</ref>.</s><s>We confirmed expression of both proteins in DN2-derived leukemia, including the myeloid and biphenotypic fractions <ref type="bibr">(Fig 4A and Appendix Fig S4A and B)</ref>, and generated a series of lentiviral constructs expressing different shRNAs to silence either factor <ref type="bibr">(Appendix Fig S4C and D)</ref>.</s><s>Indeed, knocking down Bcl11b or Gata3 impaired growth of DN2-but not GMP-derived leukemia in culture, and completely abolished DN2-leukemic development in transplanted animals .</s><s>Because both factors are important for normal T cells but not myeloid cells, we flowsorted the DN2-derived biphenotypic and myeloid fractions and individually transduced them with the lentiviral shRNA constructs, revealing that both fractions required Bcl11b and Gata3 for growth <ref type="bibr">(Appendix Fig S4E)</ref>.</s><s>These experiments suggest that DN2leukemogenesis requires the T-cell memory.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lineage plasticity of DN2-leukemia</head><p><s>While leukemias with enhanced lineage plasticity have not yet been linked to a distinct cell-of-origin, a good candidate is stem cells A GSEA demonstrates that Myc/Bcl2 + DN2-derived myeloid blasts were significantly (FDR ≥ 0.05) enriched for expression of a pan-dendritic cell gene set.</s><s>Gene sets were published in <ref type="bibr" target="#b66">Schonheit et al (2013)</ref>.</s><s>B Heat map of the top 100 differentially expressed genes (adjusted P-value of ≤ 0.05) in each myeloid fraction (ML: CD11b + Gr1 + /CD3 À CD4 À CD8 À ) from GMP-, LSK-, and DN2-derived leukemias.</s><s>C Dendrogram revealing transcriptional relationships between Myc/Bcl2 + DN2-, LSK-, and GMP-derived myeloid blasts based on unsupervised hierarchical clustering of all probes on the microarray.</s><s>D GSEA demonstrates significant enrichment of a normal DN2-specific gene set (see Materials and Methods section) in the Myc/Bcl2 + DN2-derived myeloid blasts.</s><s>A Representative FACS plots of splenocytes from diseased secondary recipients that were transplanted with 10 4 to 10 5 flow-sorted myeloid leukemia blasts (ML: CD11b + Gr1 + /CD3 À CD4 À CD8 À ) from sick primary Myc/Bcl2 + LSK-, GMP-, or DN2-transplanted mice.</s><s>Cell percentages in indicated gates are shown.</s><s>B Table summarizing the phenotype frequencies within the spleens of secondary recipients that were retransplanted with Myc/Bcl2 + LSK-, GMP-, or DN2-derived myeloid blasts as described in (A).</s><s>T-lymphoid leukemia: (TL: CD11b À Gr1 À /CD3 + CD4 + CD8 + ), biphenotypic leukemia: BL (CD11b + Gr1 + /CD3 + CD4 + CD8 + ), myeloid leukemia: ML (CD11b + Gr1 + /CD3 À CD4 À CD8 À ).</s><s>Numbers before the dash represent mice holding the indicated leukemia fraction; numbers after the dash indicate the total mouse count analyzed.</s><s>C Single myeloid blasts from four different Myc/Bcl2 + DN2-derived leukemias were flow-sorted from transplanted mice and grown on irradiated OP9:OP9-DL1 stroma.</s></p><p><s>The</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DN2-leukemia is distinct from human ETP-ALL</head><p><s>We next set out to identify a human disease that may correlate with murine DN2-leukemia.</s><s>Comparison of orthologous gene expression has recently been used to define a novel human T-cell acute lymphoblastic leukemia (T-ALL) that shows co-expression of myeloid and stem cell markers <ref type="bibr" target="#b12">(Coustan-Smith et al, 2009)</ref>.</s><s>Based on gene expression similarity with murine early T-cell precursors (ETP), representing a DN1 subpopulation, this disease has been speculated to originate from ETPs and was congruently termed ETP-ALL <ref type="bibr">(Neumann et al, 2012)</ref>.</s><s>Thus, using GSEA, we tested whether murine DN2-leukemia corresponds to human ETP-ALL; however, we detected a negative correlation between both leukemia types using two independently published ETP-ALL gene expression signatures <ref type="bibr">(Appendix Fig S6A and B)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A cohort of immature human AML cases resembles mouse DN2-leukemia</head><p><s>To determine a possible human counterpart of mouse DN2leukemia, we conducted an exploratory search concentrating on myeloid entities (AMLs).</s><s>We used the set of the top 100 up-and downregulated genes (P ≤ 0.05) in the analyzed myeloid blasts from our mouse model, and compared it to the transcriptomes of 542 human AML samples <ref type="bibr" target="#b30">(Haferlach et al, 2010)</ref>.</s><s>Indeed, the DN2derived myeloid leukemia gene signature was similar to 26 samples (frequency: 4.8%) as assessed via a Spearman's rank correlation coefficient higher than 0.5 <ref type="bibr">(Fig 6A and Dataset EV4)</ref>.</s><s>A bootstrapping approach (see Materials and Methods) yielded a highly significant enrichment value (P = 0.006) of the mouse DN2-leukemia signature in the human samples, thus confirming a non-random correlation.</s><s>All DN2-like human AML samples of which metadata were available (8 of the 26 patients) had an immature phenotype, as evident from their French-American-British (FAB) classification as M0 (2 patients), M1 (1 patient), or M2 subtypes (5 patients), whereas the whole cohort consisted of M0-M6 patients (Dataset EV5).</s></p><p><s>We next validated this finding using a second human AML dataset <ref type="bibr" target="#b76">(Verhaak et al, 2009)</ref> as it contained metadata for all patients, and focused on the FAB M2 subtype to achieve higher comparability within the samples.</s><s>We identified nine M2 AMLs resembling the murine DN2-leukemia, which clustered together and were significantly enriched for the mouse DN2-myeloid leukemia signature (Fig <ref type="figure" target="#fig_4">6B and C</ref>).</s><s>Their mutational spectrum resembled that of other AMLs <ref type="bibr">(Appendix Fig S7A and Dataset EV4)</ref>.</s><s>Moreover, the DN2-like M2 AML patients expressed significantly more GATA3 and BCL11B as well as T-cell receptor alpha (TRAC) transcripts, but had unchanged MYC levels <ref type="bibr">(Fig 6D and Appendix Fig S7B and C)</ref>.</s><s>They also had DC-like transcriptional identity <ref type="bibr">(Fig 6E)</ref>.</s><s>Collectively, transcriptome comparisons identified a potentially novel cohort of immature human AMLs that resembles mouse DN2-derived leukemia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DN2-leukemia is refractory to standard AML therapeutic agents</head><p><s>Because lineage plasticity represents a possible non-mutational mechanism for cancer cells to escape therapy <ref type="bibr" target="#b25">(Glickman &amp; Sawyers, 2012)</ref>, we used our mouse model to test if Myc/Bcl2 + DN2-derived blasts would be refractory to standard AML drugs <ref type="bibr" target="#b21">(Estey, 2009)</ref>.</s><s>Indeed, compared to their GMP-derived counterparts, DN2-derived cells were significantly less sensitive to the anthracyclines daunorubicin and doxorubicin in vitro (Fig <ref type="figure" target="#fig_6">7A</ref>).</s><s>The EMBO Journal Lineage infidelity in myeloid leukemia Pia Riemke et al</s></p><p><s>An in vivo shRNA screen reveals sensitivity to Jak2/Stat3pathway inhibition</s></p><p><s>We next sought to explore other therapeutic options to target DN2leukemia.</s><s>To this end, we conducted an in vivo genetic loss-of-function screen using an in-house generated retroviral library expressing shRNAs against 142 genes selected for their general roles in leukemogenesis and/or HSC function (Dataset EV6).</s><s>We isolated primary Myc/Bcl2 + DN2-leukemic cells from diseased mice and transduced them with the pooled shRNAs (Fig 7B To corroborate a functional role of Jak/Stat signaling, we retrovirally transduced five Myc/Bcl2 + cell lines derived from independent primary DN2-leukemic mice with two different shRNAs targeting Jak2.</s><s>After demonstrating Jak2 knockdown (Appendix Fig S8B <ref type="figure">)</ref>, we performed proliferation assays in culture (Fig <ref type="figure" target="#fig_6">7E</ref>).</s><s>Indeed, with the exception of one outlier, Jak2 knockdown reproducibly impaired proliferation of the DN2-leukemic lines.</s></p><p><s>Jak2 (and Jak1) can be selectively inhibited by ruxolitinib, which is approved for the treatment of myelofibrosis <ref type="bibr" target="#b72">(Treanor et al, 2014)</ref>.</s><s>To determine whether ruxolitinib would have an anti-proliferative effect, we cultured murine Myc/Bcl2 + DN2leukemic lines with the drug and measured proliferation.</s><s>To test specificity, we also treated cell lines derived from sick Myc/Bcl2 + GMP-and LSK-transplanted mice.</s><s>All of the DN2-but none of the GMP-or LSK-derived lines showed a significant retardation in cell growth <ref type="bibr">(Fig 7F and Appendix Fig S8C)</ref>.</s><s>We confirmed activated STAT3 and its inhibition by ruxolitinib in the DN2-leukemic lines <ref type="bibr">(Fig 7G)</ref>.</s><s>Finally, significant enrichment of JAK/STAT signaling signature genes suggested that this pathway is also activated in human DN2-like M2 AML cells <ref type="bibr">(Fig 7H)</ref>.</s><s>Collectively, these results propose Jak2/Stat3 signaling as a potentially druggable target in DN2-leukemogenesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In the present study, we demonstrated that oncogene-transformed murine DN2 T-cell progenitors harbor malignant multi-lineage capacity and a high intrinsic potential to transdifferentiate into myeloid and biphenotypic leukemia.</s><s>Focusing particularly on the myeloid disease, we showed that DN2-derived leukemia is characterized by several unique features: It has (i) transcriptional similarity with DCs, (ii) functional thymic origin memory, (iii) persisting myeloid/T-lymphoid plasticity, (iv) resistance to standard chemotherapy, and (v) dependency on Jak2/Stat3 signaling.</s><s>Importantly, we identified a possibly correlating human AML cohort (comprising ~5% of all cases) of potential thymic origin and pathogenesis similar to the murine disease.</s><s>Congruently, the disease of the human cohort may represent a new subgroup of thymus-derived AML.</s><s>Moreover, our results propose a general model in which notyet-fully stabilized competing differentiation states of developing progenitors shape plastic lineage identities in cancer.</s></p><p><s>Leukemic lineage outcomes of T-cell progenitors have not yet been systematically investigated.</s><s>To dissect possible lineage fate options of transformed DN2 cells, we delivered ectopic expression of Myc together with Bcl2 and compared these cells with equally treated LSK and GMP cells.</s><s>In humans, MYC expression is increased (e.g., through activating NOTCH1 mutations) in more than 50% of T-ALLs <ref type="bibr" target="#b53">(Palomero et al, 2006;</ref><ref type="bibr" target="#b80">Weng et al, 2006)</ref> and more than 40% of AMLs <ref type="bibr" target="#b39">(Larramendy et al, 2002;</ref><ref type="bibr" target="#b11">Court et al, 2004)</ref>.</s><s>Overall, this highlights that MYC is among the most A Survival assay of Myc/Bcl2 + GMP-and DN2-derived leukemia cells that were isolated from diseased mice and treated for 24 h with 0.15 lM daunorubicin or 1 lM doxorubicin in liquid culture.</s><s>Cell death was measured by FACS of 7-AAD + cells and was normalized to the solvent controls.</s><s>The graphs show the mean+SEM of three different DN2-and five GMP-leukemias.</s><s>**P ≤ 0.01, two-tailed Student's t-test.</s><s>B Experimental procedure of the shRNA library in vivo screen.</s><s>Blasts from leukemic mice that were transplanted with Myc/Bcl2 + DN2-cells were infected with a retroviral shRNA library consisting of ~300 GFP-or YFP-tagged shRNAs targeting a total of 142 different genes.</s><s>Cells were harvested 72 h postinfection, the GFP + and YFP + fractions were flow-sorted, and 6 × 10 4 cells were transplanted into secondary recipients.</s><s>The residual cells were expanded for five days on OP9:OP9-Dll1 1:1 layers for amplification (T0 reference samples).</s><s>Secondary recipients were sacrificed after development of leukemia, and T1 samples were generated from BMs, spleens, and thymi, which confirmed BM infiltration &gt; 20%).</s><s>T1 and T0 samples were deep sequenced, and changes in individual shRNAs were calculated.</s><s>C Scatterplot depicting the averaged quantitative changes (log10) of each shRNA within the library in the T1 spleen and BM samples in reference to T0.</s><s>The changes in both organs were concordant (R 2 = 0.72).</s><s>T1 samples from 11 mice were compared to 3 T0 reference samples.</s><s>Blue dots represent shRNAs with a significant depletion by ≥ 10-fold.</s><s>D Top five genes with ≥ 10-fold shRNA depletion in BM, spleen, and thymus in comparison with the reference.</s><s>E Percent cell growth of five different DN2-derived leukemic cell lines transduced with two different shRNA constructs targeting Jak2.</s><s>The cells were sorted for the GFP or YFP reporter and normalized to the control shRNA targeting the lacZ gene (lacZ).</s><s>Four of five DN2-derived leukemias show reduced growth with both shRNAs after the second round of sorting within eight days in culture.</s><s>The lacZ control was set to 100%.</s><s>F Proliferation curves of 3 Myc/Bcl2 + DN2-and 3 GMP-derived leukemia lines during treatment with 0.5 lM ruxolitinib.</s><s>1.5 × 10 5 cells were seeded in culture and counted at the indicated time points.</s><s>Results are shown as fold growth relative to the starting cell number which was set to 1. *P ≤ 0.05, **P ≤ 0.01, Student's t-test.</s></p><p><s>Error bars define standard deviation (SD), number of replicates n = 3. G Western blot indicating active Jak/Stat signaling in DN2-derived leukemia with Stat3 as well as pStat3 protein expression that diminishes after treatment with the Jak-inhibitor ruxolitinib.</s><s>H GSEA indicating significant enrichment of genes of the JAK/STAT signaling pathway of the KEGG pathway database in the DN2-like M2 AML samples as compared to the residual M2 AML samples using the Verhaak AML dataset <ref type="bibr" target="#b76">(Verhaak et al, 2009)</ref>.</s><s>The EMBO Journal Lineage infidelity in myeloid leukemia Pia Riemke et al frequently upregulated proto-oncogenes in human acute leukemias and thus represents a useful model in our study.</s><s>Although there are already published experimental examples of lymphoid/myeloid infidelity in leukemia, it has remained unclear if the transforming oncogenic events inadvertently activate this plasticity, thus overshadowing the possibility that plasticity is an endogenous characteristic of the transformed cells.</s><s>MYC has been suggested to function as a general amplifier of gene expression rather than activating specific target gene sets <ref type="bibr" target="#b41">(Lin et al, 2012;</ref><ref type="bibr" target="#b52">Nie et al, 2012)</ref>.</s></p><p><s>Although this view has recently been challenged <ref type="bibr" target="#b63">(Sabo et al, 2014;</ref><ref type="bibr" target="#b36">Koh et al, 2015)</ref>, our single cell-based experiments suggest at the functional level that ectopic Myc expression "freezes" endogenous lineage fate options because the lineage outcomes of Myctransformed progenitors were similar to those of their healthy counterparts <ref type="bibr" target="#b0">(Bell &amp; Bhandoola, 2008;</ref><ref type="bibr" target="#b77">Wada et al, 2008;</ref><ref type="bibr" target="#b56">Richie Ehrlich et al, 2011)</ref>.</s><s>Thus, ectopic Myc expression appeared instrumental to dissect endogenous lineage options of transformed hematopoietic cells.</s><s>Moreover, transformation of DN2 cells by MLL-AF9 also produced multi-lineage leukemias, providing further evidence for an intrinsic myeloid/T-lymphoid potential.</s><s>Finally, this conclusion also agrees with the myeloid-based model of hematopoiesis, which explains the retained myeloid potential in other lineages <ref type="bibr" target="#b34">(Kawamoto et al, 2010)</ref>.</s></p><p><s>We focused our study primarily on the myeloid fraction of Myc/ Bcl2 + DN2-derived leukemia and found several unique properties, one of which was expression of DC genes.</s><s>Previous reports have shown DC potential of healthy thymic progenitors <ref type="bibr" target="#b40">(Li et al, 2009;</ref><ref type="bibr" target="#b48">Moore et al, 2012)</ref>, thus explaining our observation that DC-like blasts arise from transformed DN2 cells.</s><s>Another unique feature of DN2-derived myeloid blasts was that they expressed a gene set shared by normal DN2 T-cell progenitors.</s><s>This set likely represents an inherited transcriptional ancestor memory and includes genes encoding important T-cell transcription factors such as Bcl11b and Gata3, which, as our knockdown data show, are required for DN2leukemia growth.</s><s>Congruently, genes of the T-cell origin memory are of functional importance.</s></p><p><s>Another important question we addressed in this study was if mouse model DN2-leukemia has a human disease counterpart.</s><s>We approached this by comparing orthologous gene expression.</s><s>The most obvious correlating human disease seemed to be the recently described ETP-ALL, which is believed to arise from the earliest thymic precursors and expresses lymphoid together with myeloid and stem cell antigens on the diseased cells <ref type="bibr" target="#b12">(Coustan-Smith et al, 2009;</ref><ref type="bibr">Zhang et al, 2012;</ref><ref type="bibr" target="#b72">Treanor et al, 2014)</ref>.</s><s>However, GSEA with two independently published ETP-ALL gene signatures clearly showed that DN2-leukemia is a different disease.</s><s>Supporting this, ETP-ALL has shown stronger correlation in gene expression with human HSCs and GMPs than with ETPs <ref type="bibr">(Zhang et al, 2012)</ref>.</s><s>Moreover, ETP-ALL lacks GATA3 and BCL11B expression <ref type="bibr">(Zhang et al, 2012)</ref>, while DN2-leukemia requires both factors.</s><s>In contrast with ETP-ALL, comparing the DN2-leukemia gene signature with published AML transcriptome data <ref type="bibr" target="#b76">(Verhaak et al, 2009;</ref><ref type="bibr" target="#b30">Haferlach et al, 2010)</ref> allowed us to identify a novel patient cluster of immature AMLs that significantly resembles mouse DN2-leukemia.</s><s>Importantly, these patients expressed significantly more TCR alpha mRNA than the other AML patients.</s><s>Furthermore, our first preliminary analysis of two DN2-like AML patients from which genomic DNA was available, suggested TCR rearrangement in at least one of them (data not shown), supporting the view that a transformed T cell served as the ancestor.</s><s>The DN2-like human AMLs harbored mutations in DNMT3a, FLT3, IDH1, IDH2, and NPM1, all of which are frequent in AML <ref type="bibr" target="#b22">(Falini et al, 2011;</ref><ref type="bibr" target="#b54">Patel et al, 2011;</ref><ref type="bibr" target="#b32">How et al, 2013;</ref><ref type="bibr" target="#b46">Mayle et al, 2015)</ref>.</s><s>Interestingly, with the exception of NPM1, all of these mutations have also been found in T-ALL <ref type="bibr" target="#b73">(Van Vlierberghe et al, 2005</ref><ref type="bibr">, 2013;</ref><ref type="bibr" target="#b29">Grossmann et al, 2013;</ref><ref type="bibr" target="#b51">Neumann et al, 2013)</ref>, and their occurrence in both lineages has been explained by the assumption that they were acquired in a stem cell <ref type="bibr" target="#b45">(Matutes et al, 1997;</ref><ref type="bibr" target="#b16">Dorantes-Acosta &amp; Pelayo, 2012)</ref>.</s><s>Supporting this notion, we detected significant plasticity in leukemias derived from LSK cells.</s><s>In this context, it was interesting that in addition to the polyclonal leukemic T-lymphoid fractions that developed in Myc/Bcl2 + LSK-transplanted mice, some of the animals also had monoclonal biphenotypic fractions <ref type="bibr">(Appendix Fig S9)</ref>.</s><s>This finding suggests that individual T-lymphoid leukemia clones had the plasticity to switch their phenotype in vivo.</s><s>Moreover, because we found that DN2 cells had leukemic multi-lineage potential, an important conclusion from our study could be that the same mutations in T-ALL and AML may also originate from a transformed T-cell progenitor instead of a stem cell.</s><s>In line, the view of a T-cell ancestor for certain AMLs is supported by studies that have observed frequent TCR rearrangement in MLL-translocated adult AML and the hypogranular variant subtype of acute promyelocytic leukemia (APL) <ref type="bibr" target="#b17">(Dupret et al, 2005;</ref><ref type="bibr" target="#b9">Chapiro et al, 2006)</ref>.</s></p><p><s>Our data suggest that biphenotypic leukemia-now termed mixed-lineage acute leukemia (MPAL) by the WHO <ref type="bibr" target="#b2">(Borowitz et al, 2008)</ref>-may develop from T-cell progenitors as well.</s><s>Many of these cases carry rearrangement or deletions of the TCR or immunoglobulin heavy chain genes <ref type="bibr" target="#b3">(Buccheri et al, 1993)</ref>, underlining the idea that a transformed lymphoid progenitor with residual myeloid potential could be their origin.</s><s>Importantly, patients with biphenotypic leukemia have a worse clinical outcome than matched AML or ALL patients, and there is no set therapy for this disease (reviewed in <ref type="bibr" target="#b79">Weinberg &amp; Arber, 2010)</ref>.</s><s>Hence, pathogenic mechanisms leading to biphenotypic leukemia are of high clinical interest.</s></p><p><s>A key feature of DN2-leukemia in mice was its myeloid/ T-lymphoid plasticity, which we linked to dynamic PU.1 expression.</s><s>PU.1 is an important transcription factor for myeloid differentiation, and forcing its expression can lead to reprogramming of normal lymphoid into myeloid cells <ref type="bibr">(Laiosa et al, 2006a,b)</ref>.</s><s>During normal T-cell development, PU.1 expression is switched off between the DN2 and DN3 stages, representing the point in time when myeloid potential is lost <ref type="bibr" target="#b61">(Rothenberg et al, 2008)</ref>.</s><s>From the results presented herein, it appears that the DN2-derived leukemia blasts inherited a unique epigenetic flexibility to dynamically control PU.1 expression from their healthy ancestors.</s><s>Importantly, because our single-cell assays revealed that not all DN2-derived blasts had the same potential to switch phenotype, it is likely that this epigenetic flexibility is confined to special plastic cells within the leukemia population.</s><s>On the other hand, lineage plasticity in leukemia can also result from particular properties of the transforming oncogene.</s><s>For example, the CALM-AF10 t(10:11) fusion product can drive transdifferentiation of B-cell progenitors into leukemia with a myeloid phenotype <ref type="bibr" target="#b14">(Deshpande et al, 2006)</ref>.</s><s>Thus, lineage infidelity in leukemia likely involves both intrinsic programs inherited from the healthy ancestor cells and epigenetic properties as a result of the transforming events.</s><s>Why might lineage infidelity be advantageous for a leukemia cell?</s><s>The answer might relate to the fact that lineage switching can be observed after treatment-associated leukemia relapse; this switching includes the conversion of myeloid to lymphoid leukemia or vice versa <ref type="bibr" target="#b69">(Stass et al, 1984;</ref><ref type="bibr" target="#b23">Gagnon et al, 1989;</ref><ref type="bibr" target="#b42">Liso et al, 1998)</ref>.</s><s>Indeed, lineage plasticity in human leukemia is associated with particularly poor survival <ref type="bibr" target="#b45">(Matutes et al, 1997;</ref><ref type="bibr" target="#b35">Killick et al, 1999;</ref><ref type="bibr" target="#b27">Golemovic et al, 2006)</ref>.</s><s>In this context, we also investigated a drug response scenario and found that treating DN2-leukemic cells with daunorubicin or doxorubicin-both frequently used drugs for human AML therapy <ref type="bibr" target="#b20">(Estey &amp; Dohner, 2006;</ref><ref type="bibr" target="#b21">Estey, 2009)</ref>-negligibly affected the survival of Myc/Bcl2 + DN2-leukemic cells.</s><s>Therefore, we were eager to uncover pathways in DN2-leukemia that might serve as druggable targets.</s><s>Because shRNA libraries are instrumental for identifying such targets <ref type="bibr" target="#b47">(Miller et al, 2013;</ref><ref type="bibr" target="#b68">Sroczynska et al, 2014)</ref>, we developed a retroviral shRNA library and conduced an in vivo genetic loss-of-function screen.</s><s>Importantly, Jak2 and Stat3 arose as top candidates.</s><s>JAK2 mutations are frequent in polycythemia vera <ref type="bibr" target="#b67">(Scott et al, 2007)</ref>, thrombocythemia <ref type="bibr" target="#b4">(Campbell et al, 2005)</ref>, and myelofibrosis <ref type="bibr" target="#b6">(Campbell et al, 2006)</ref>, and specific JAK2 inhibitors such as ruxolitinib are now in clinical use <ref type="bibr" target="#b18">(Eghtedar et al, 2012;</ref><ref type="bibr" target="#b31">Harrison et al, 2012)</ref>.</s><s>Indeed, ruxolitinib treatment led to impaired growth of DN2-but neither GMP-nor LSK-derived leukemia, indicating that JAK2 inhibition may be clinically beneficial.</s><s>This view is supported by our finding that the human DN2-like AML samples also had enriched expression of the KEGG database JAK/STAT pathway signature, indicative of activated JAK/STAT signaling.</s></p><p><s>Taken together, this study presents evidence that T-cell progenitors may represent the cellular origin of a unique type of lineageunstable leukemia.</s><s>More generally, our results propose that in cancer, the cells' associated plasticity, growth, and therapy responses can be the result of genetic programs inherited from healthy ancestor cells.</s><s>Thus, determining the ancestry of human cancers may aid the development of better treatment protocols.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mice and cell lines</head><p><s>Thymus and BM were extracted from 6-to 12-week-old WT BL6 (C57BL/6) donor mice, purchased from Charles River Laboratories.</s><s>Myc/Bcl2 + LSKs, GMPs, or DN2 cells were intravenously or intrathymically injected into B6.SJL (B6.SJL-Ptprca/BoyAiTac) congenic recipient mice.</s><s>BL6 mice express CD45.2 (Ly5.2;</s><s>Ptprc; protein tyrosine phosphatase, receptor type, C) and B6.SJL CD45.1 (Ly5.1;</s><s>Ptprc; protein tyrosine phosphatase, receptor type, C), allowing for distinction of leukemic donor and healthy recipient cells.</s><s>All mouse experiments were approved by the local authorities according to the German Federal Animal Protection Act.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transplantation experiments</head><p><s>For cell transfer, we used 4-to 8-week-old recipient mice that received 4.5-6 Gy total body irradiation with the 18 MeV photon beam of a linear electron accelerator using a dose rate of 6.79 Gy/min or the Faxitron CP160 X-ray irradiation system with 0.55 Cu filter and a dose of 0.603 Gy/min. 2 × 10 4 -1 × 10 6 malignant cells were intravenously injected.</s><s>Leukocytosis with blast counts &gt; 10% in peripheral blood derived from donor cells indicated acute leukemia (20% bone marrow infiltration).</s><s>If recipient animals showed physical signs of full-blown leukemia (hind limb paralysis, loss of body weight, palpable spleen, or submandibular lymph nodes), they were euthanized.</s><s>Intrathymic injections were performed as previously described <ref type="bibr" target="#b26">(Goldschneider et al, 1986)</ref>.</s><s>Recipient mice were narcotized with a mixture of ketaminexylazine, fixated with the ventral side pointing upwards the sterilized thorax area, and opened with a medial longitudinal skin section to expose the thymus.</s><s>3 × 10 4 donor cells were injected with a 27G canula into the two lobes of the thymus and the incision closed with wound clips.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histology</head><p><s>Maximally 1 × 10 4 of cells were cytospun (Tharmac) at 33.5 g for 10 min onto object slides.</s><s>Air-dried object slides were fixed in methanol for 10 min and incubated 10 min in May-Gruenwald staining solution (Sigma-Aldrich).</s><s>Slides were washed with water and stained with Giemsa staining solution (Sigma-Aldrich) for 40 min.</s><s>After the final washing step with water, slides were airdried and closed with a drop of Roti â -Histokitt II and cover slips.</s><s>For histology, parts of the spleen, sternum, or liver were transferred into a Histofix solution (Roth) and cross sections were prepared as described previously <ref type="bibr" target="#b19">(Erny et al, 2015)</ref>.</s><s>May-Gruenwald Giemsa (MGG) and Myeloperoxidase (Ab-1, RB 373-A0 Thermo Scientific, 1:200) staining was conducted, and the slides were photographed with an Axioplan2 microscope/camera system (Zeiss).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometry and cell sorting</head><p><s>Twenty 4-to 5-week-old donor mice were sacrificed per experiment to obtain approximately 5 × 10 4 DN2 cells from thymi and 6 × 10 4 LSK and 1 × 10 5 GMP from BM washout.</s><s>Single-cell suspensions from thymi and BM were stained with the following antibodies conjugated with V450, PE, APC, or FITC: CD3 (500A2), CD4 (RM4-5), CD8a (53-6.7),</s><s>CD19 (1D3), Gr1 (RB6-8C5), CD11b (M1/70), CD45R/B220 (RA3-6B2), CD25 (PC61), FccRII/III (2.4G2), CD34 (RAM34), Sca-1 (D7), and c-Kit (2B8).</s><s>Thymic and BM suspensions were incubated with CD117 (c-Kit) mouse microbeads (Miltenyi) according to the instructions of the supplier and enriched for c-Kit via magnetic cell separation in MACS LS columns (Miltenyi).</s><s>Cell sorting was performed with a high-speed multi-color cell sorter (Aria II or III).</s><s>Thymic precursors were defined via surface markers as described previously <ref type="bibr" target="#b77">(Wada et al, 2008)</ref>.</s><s>All cells were sorted by exclusion of 7-AAD + dead cells as well as doublets.</s><s>After sorting, an aliquot of the sorted fractions was used for re-analysis and confirmation of at least 95% sort purity.</s></p><p><s>Primary leukemias were analyzed by FACS with antibodies against CD3 (145-2C11), CD4 (RM4-5), CD8 (53-6.7),</s><s>CD11b (M1/ 70.15), Gr1 (RB6-8C5), CD45.1 (A20) and CD45.2 (104), TCR beta (H57-597), or TCR gamma/delta (GL3) conjugated with PE, APC, Pacific and Alexa Fluor 700.</s><s>Intracellular CD3 staining was performed by Cell Fixation/Permeabilization Kits (BD).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasmids</head><p><s>MSCV-c-Myc-IRES-Bcl2 was described in <ref type="bibr" target="#b43">Luo et al (2005)</ref>.</s><s>The shRNA library was subcloned into the PINCO-RFB-GFP-IRES-RE9 <ref type="bibr" target="#b28">(Grignani et al, 1998)</ref> following the BLOCK-iT TM Pol II miR RNAi Expression Vector Kit (Invitrogen) together with the Gateway â technology (Invitrogen).</s><s>shRNAs against Bcl11b, Gata3, and luciferase were subcloned into the pRSI9-U6-(sh)-UbiC-TagRFP-2A-Puro (Addgene) following the Cellecta protocol.</s><s>All shRNA sequences are available on request.</s><s>The plasmids pLP1, pLP2 and VSVG, and pcDNA TM 6.2-GW/AE EmGFP-miR-lacZ were from Invitrogen.</s><s>MSCV-IRES-GFP-IRES-PU.1 was described in <ref type="bibr" target="#b58">Rosenbauer et al (2004)</ref> and MSCV-IRES-GFP in <ref type="bibr" target="#b33">Huntly et al (2004)</ref>.</s></p><p><s>In vitro colony forming assays and single-cell sorts Semi-solid culture of transformed precursors in methylcellulose was used to generate immobilized colonies; 24-h postinfection, ~1,000 Myc/Bcl2-transduced cells were plated in methylcellulose (M3234, Stem Cell Technologies) supplemented with 10 ng/ml IL-2, IL-3, IL-6, IL-7, SCF, GM-CSF, FLT3, and 20 lg/ml gentamicin; 500 ng/ml Fungizole; and 20 lg/ml ciprofloxacin.</s><s>Methylcellulose suspensions were plated onto 35-mm cell culture dishes for 5-7 days before leukemic colonies were picked and separately expanded in a 96-well plate with fresh methylcellulose.</s><s>Clones were expanded for extraction of genomic DNA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blot analysis</head><p><s>Protein samples were prepared as described in <ref type="bibr" target="#b59">Rosenbauer et al (2006)</ref>.</s><s>Proteins were detected with the antibodies anti-Ctip2/Bcl11b (25B6) (Abcam), anti-GATA-3 (510-20) (Abcam), anti-b-actin (AC-15 or A2066) (Sigma-Aldrich), anti-a-tubulin (B-5-1-2) (Santa Cruz), anti-VCP (5) (Abcam), anti-PU.1 (T-21X) (Santa Cruz), anti-pStat3 (Tyr705) (D3A7) (Cell Signaling Technology), and anti-Stat3 (124H6) (Cell Signaling Technology).</s><s>For the detection of horseradish peroxidase coupled secondary antibodies, the ECL kit (Invitrogen) was used.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene expression profiling</head><p><s>The Affymetrix GeneChip â (Mus musculus) MG 430 PM was applied to investigate the expression of approximately 45,000 features in flow-sorted LSK-, GMP-, and DN2-derived myeloid leukemia cells.</s><s>Sample processing and microarray hybridization were carried out at the Center of Excellence for Fluorescent Bioanalytics (KFB, University of Regensburg, Germany).</s><s>The raw gene expression data were imported into R (R Core Team, 2015) and RMA normalized with the R package "affy" <ref type="bibr" target="#b24">(Gautier et al, 2004)</ref>.</s><s>Murine gene signature generation, gene set enrichment analysis, and identification of human AML samples correlating to mouse DN2-leukemia are described in detail in the Appendix Supplementary Methods.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>No statistical methods were used to predetermine sample sizes, and exact group numbers were determined by animal availability.</s><s>However, we did ensure that our sample sizes were similar to those generally employed in the field.</s><s>To obtain unbiased data, experimental mice were not randomized or blinded but processed by scientists together with technicians and cell quantifications were performed by two scientists independently and separately.</s><s>Microarray analysis was blinded, and sample preparation, processing, and analysis were performed by different scientists.</s></p><p><s>Two-tailed Student's t-test was carried out to determine the statistical significance of experimental results for normally distributed values.</s><s>*P ≤ 0.05 and **P ≤ 0.01.</s><s>Alternatively, Wilcoxon rank-sum tests were used to determine statistical significance.</s><s>**P ≤ 0.01.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accession codes</head><p><s>GEO: array data, GSE80739.</s></p><p><s>Expanded View for this article is available online.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .Figure 2 .</head><label>12</label><figDesc><div><p><s>Figure 1.</s><s>Single DN2 cells possess malignant myeloid and T-lymphoid potential.</s><s>A Representative FACS plot (left) showing a mixed-lineage clone with a T-lymphoid (CD25 + /CD11b À Gr1 À ), myeloid (CD11b + Gr1 + /CD25 À ), and biphenotypic (CD11b + Gr1 + / CD25 + ) fraction derived from a single Myc/Bcl2-transformed DN2 cell grown on 1:1 OP9:OP9-Dll1 co-culture with lineage-promiscuous cytokines IL-2, IL-3, IL-6, IL-7, SCF, GM-CSF, Flt3.</s><s>Morphology of the indicated flow-sorted cell fractions was analyzed by Giemsa staining (right).</s><s>B Phenotype frequencies of clones from Myc/Bcl2-transformed single cells (grown and phenotyped as mentioned in A).</s><s>Analyzed were 31 clones from LSKs, 107 from GMPs and 28 from DN2 cells.</s><s>C Mice that received 5 × 10 4 to 5 × 10 5 T-lymphoid cells or myeloid cells flow-sorted from mixed Myc/Bcl2 + DN2-derived clones showed a cumulative survival of 31 AE 2 and 27 AE 6 days respectively.</s><s>The summarized data are from three mice injected with the T-lymphoid and four mice injected with the myeloid fraction of two different clones.</s><s>D Representative FACS plots demonstrating predominant outgrowth of myeloid clones from single Myc/Bcl2-transformed LSK or GMP cells on OP9:OP9-Dll1 co-cultures.</s><s>E (top panels) Serial replating of Myc-Bcl2 + DN2 cells in methylcellulose generated myeloid clones with stable genomic reassembly of the Db1 TCR locus in vitro (gel: left two lanes).</s><s>Upon transplantation, the same clones induced myeloid leukemia that retained the initial rearrangement in vivo (gel: right two lanes) as assessed by nested PCR.</s><s>GL = germline.</s><s>(bottom panels) Methylcellulose-based replating of Myc-Bcl2 + GMPs generated myeloid clones that exclusively displayed the TCRb locus in germline configuration.</s><s>F Cumulative survival of mice that received 10 6 cells of TCRb-rearranged myeloid DN2-derived clones leading to death 33 AE 4 days after transplantation.</s><s>Two DN2 clones were transplanted into five recipient mice.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. DN2-myeloid leukemia retains a T-cell memory.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>▸ ª 2016 Figure 4 .Figure 5 .</head><label>201645</label><figDesc><div><p><s>Figure 3.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>clones were analyzed at two different time points.</s><s>FACS plots of two representative clones, one with strong (top), and one with weak (bottom) lineage switching potential are shown.</s><s>D Table summarizing the lineage switching outcome of 20 independent clones that were grown from single DN2-derived myeloid blasts of four different leukemias.</s><s>Percentages at the right indicate the relative amounts of cells with T-lymphoid (TL), biphenotypic (BL), or myeloid (ML) phenotype as analyzed by FACS at the end of the experiment.</s><s>E FACS plot of DN2-derived primary leukemic cells transduced with a retrovirus carrying GFP alone or GFP together with PU.1 as a bicistronic RNA.</s><s>The transduced cells were grown on OP9/OP9-Dll1 1:1 layer for 8-13 days and analyzed using a GFP gate.</s><s>The data are representative of 3 different experiments with similar outcome.</s><s>The EMBO Journal Vol 35 | No 22 | 2016 ª 2016 The Authors The EMBO Journal Lineage infidelity in myeloid leukemia Pia Riemke et al only DN2-derived blasts were able to completely convert from the myeloid into a T-lymphoid phenotype in vivo.</s><s>We next sorted single myeloid blasts from DN2-leukemic mice onto OP9:OP9-DL1 stromal cells, and confirmed their potential to switch phenotype at the clonal level (Fig 5C).</s><s>Intriguingly, not all clones possessed plasticity to the same extent (Fig 5D), suggesting that the cells in the myeloid fraction had differential lineage potential.We also assessed plasticity of the T-lymphoid and biphenotypic populations from Myc/Bcl2 + LSK-and DN2-derived leukemias upon transplantation into secondary recipients; we found comparable abilities to switch between T-lymphoid and biphenotypic states, but low abilities to adopt the myeloid phenotype(Appendix Fig S5A).</s><s>Taken together, these experiments demonstrate significant plasticity in both LSK-and DN2-derived leukemias and reveal a unique lineage switching capacity especially in the DN2-derived myeloid leukemia population.PU.1 expression can determine plasticity in DN2-leukemiaPU.1 strongly regulates myeloid gene expression<ref type="bibr" target="#b60">(Rosenbauer &amp; Tenen, 2007)</ref> and is expressed in the myeloid and biphenotypic but not T-lymphoid fraction of DN2-leukemia (Fig 2D).</s><s>To test whether dynamic PU.1 expression determines lineage conversion of Myc/ Bcl2 + DN2 cells, we transduced DN2-leukemia bulks from sick mice with a retrovirus coexpressing PU.1 and GFP and analyzed lineage distribution in culture.</s><s>While control virus-transduced cells predominantly gave rise to progeny with T-lymphoid markers, PU.1expressing cells produced mainly myeloid or biphenotypic progeny (Fig 5E).</s><s>Next, we transduced flow-sorted T-lymphoid cells from DN2-derived leukemias with the PU.1-expressing retroviruses.</s><s>After just 4 days, forced PU.1 expression reprogrammed most of them into biphenotypic or, to a lesser extent, myeloid blasts (Appendix Fig S5B), suggesting that dynamic PU.1 expression may dictate lineage outcome in DN2-derived leukemia.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>A cohort of immature human AML patients resembles mouse DN2-leukemia.</s><s>A Heat map depicting all human AML samples from the Haferlach study (Haferlach et al, 2010) whose transcriptomes resembled DN2-leukemia by a Spearman's rank correlation coefficient ≥ 0.5.</s><s>The top 100 up-and downregulated gene signature of Myc/Bcl2 + DN2-derived myeloid blasts was applied (see also Fig 3B).</s><s>B Hierarchical clustering of all FAB M2 AML samples from the Verhaak study (Verhaak et al, 2009) based of the Myc/Bcl2 + DN2-derived myeloid blast top 100 upregulated (UP) gene signature (see Fig 3B).</s><s>C-E GSEA confirming enrichment of the Myc/Bcl2 + DN2-derived myeloid blast top 100 UP (C) and pan-DC (Schonheit et al, 2013) (E) gene signatures in the human FAB M2 DN2-like AML samples as compared to all residual M2 AMLs from the Verhaak study (Verhaak et al, 2009).</s><s>(D) Relative transcript levels of the T-cell receptor alpha locus (TRAC) in human DN2-like M2 AML compared to residual M2 AML patient samples from the Verhaak study (Wilcoxon rank-sum test, **P ≤ 0.01).</s><s>Boxes represent 25-75% quantiles, whiskers represent minimum and maximum values.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>▸ ª 2016 PiaFigure 6 .</head><label>20166</label><figDesc><div><p><s>Figure 6.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 7 .</head><label>7</label><figDesc><div><p><s>Figure 7.</s><s>A targeted shRNA in vivo screen reveals requirements of Jak2/Stat3 signaling in DN2-leukemia.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>▸ ª 2016 Pia</head><label>2016</label><figDesc><div><p><s>Figure 7.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>ª</head><label></label><figDesc><div><p><s>2016 The Authors The EMBO Journal Vol 35 | No 22 | 2016 Pia Riemke et al Lineage infidelity in myeloid leukemia The EMBO Journal</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="3,164.38,76.52,268.07,487.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="4,140.05,79.04,319.75,447.91" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="7,124.69,76.52,344.30,466.96" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Achim Leutz for his comments on the manuscript, Thorsten König and Margit Käse for FACS sorting, Henning Müller for technical assistance, and Celeste Brennecka for linguistic support.</s><s>This work was supported by grants from the Deutsche Forschungsgemeinschaft to F.R., C.M.T., and G.L., the University of Münster Medical Faculty (IZKF, Ros2/007/15) to F.R., the Deutsche Krebshilfe and the Else Kröner-Fresenius-Stiftung to G.L.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>PR and FR designed the study and wrote the manuscript.</s><s>FR supervised the entire project and provided financial support.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>The authors declare that they have no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The earliest thymic progenitors for T cells possess myeloid lineage potential</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhandoola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">452</biblScope>
			<biblScope unit="page" from="764" to="767" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Bene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Castoldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Matutes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Orfao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Van't Veer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1783" to="1786" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Acute leukemias of ambiguous lineage</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Borowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Bene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Porwit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Matutes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Swerdlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Campo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Pileri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thiele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Vardiman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">WHO Classification of Tumours of Heamatopoietic and Lymphoid Tissues</title>
				<meeting><address><addrLine>Lyon</addrLine></address></meeting>
		<imprint>
			<publisher>JARC Press</publisher>
			<date type="published" when="2008">2008</date>
			<biblScope unit="page" from="150" to="155" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Lineage commitment in biphenotypic acute leukemia</title>
		<author>
			<persName><forename type="first">V</forename><surname>Buccheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Matutes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Dyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Catovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="919" to="927" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Buck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wheatley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>East</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Marsden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duffy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Boyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Bench</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Vassiliou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Milligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Erber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bareford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Wilkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="1945" to="1953" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">The Authors The EMBO Journal</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Griesshammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dohner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dohner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kusec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Hasselbalch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pallisgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Giraudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Bousse-Kerdiles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Desterke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guerton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dupriez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bordessoule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fenaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kiladjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Viallard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Briere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis</title>
				<imprint>
			<date type="published" when="2006">2006</date>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="2098" to="2100" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Crafton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Flook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Skarica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brockstedt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Dubensky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Stins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Lanier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Pardoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Housseau</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity</title>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="207" to="213" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Expression of T-lineageaffiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17)</title>
		<author>
			<persName><forename type="first">E</forename><surname>Chapiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Delabesse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Asnafi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Millien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Davi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nugent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beldjord</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Haferlach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grimwade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Macintyre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="3484" to="3493" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Minden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Toyonaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Mak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Mcculloch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="414" to="424" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Court</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Avent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Hancock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leuk Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="743" to="753" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia</title>
		<author>
			<persName><forename type="first">E</forename><surname>Coustan-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Mullighan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Onciu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Behm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Raimondi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Rubnitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Basso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Biondi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Pui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Campana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="147" to="156" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Early T-cell progenitors are the major granulocyte precursors in the adult mouse thymus</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>De Obaldia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhandoola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="64" to="71" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Deshpande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cusan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Rawat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Quintanilla-Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kakadia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kuchenbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Delabesse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lichter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kneba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hiddemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Macintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mecucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Humphries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Bohlander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="363" to="374" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet</title>
		<author>
			<persName><forename type="first">H</forename><surname>Dohner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Estey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Amadori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Appelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Buchner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Burnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dombret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fenaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grimwade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lo-Coco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Naoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Niederwieser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Ossenkoppele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sierra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Tallman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lowenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bloomfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="453" to="474" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Lineage switching in acute leukemias: a consequence of stem cell plasticity?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Dorantes-Acosta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pelayo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Res</title>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page">406796</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">IgH/TCR rearrangements are common in MLL translocated adult AML and suggest an early T/myeloid or B/myeloid maturation arrest, which correlates with the MLL partner</title>
		<author>
			<persName><forename type="first">C</forename><surname>Dupret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Asnafi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leboeuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Millien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Abdelali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Preudhomme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Beldjord</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Delabesse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Macintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="2337" to="2338" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Eghtedar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Verstovsek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Estrov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cortes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bivins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Faderl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ferrajoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Borthakur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Scherle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kantarjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ravandi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="4614" to="4618" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Host microbiota constantly control maturation and function of microglia in the CNS</title>
		<author>
			<persName><forename type="first">D</forename><surname>Erny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hrabe</forename><surname>De Angelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Jaitin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wieghofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Staszewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Keren-Shaul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mahlakoiv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jakobshagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Buch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schwierzeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Utermohlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Chun</forename><forename type="middle">E</forename><surname>Garrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Mccoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Diefenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Staeheli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Stecher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Amit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Prinz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Neurosci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="965" to="977" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Acute myeloid leukaemia</title>
		<author>
			<persName><forename type="first">E</forename><surname>Estey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dohner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page" from="1894" to="1907" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Treatment of acute myeloid leukemia</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Estey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="10" to="16" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy</title>
		<author>
			<persName><forename type="first">B</forename><surname>Falini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gionfriddo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cecchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ballanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pettirossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Martelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Rev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="247" to="254" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Molecular heterogeneity in acute leukemia lineage switch</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Gagnon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Childs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lemaistre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Keating</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Trujillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Freireich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Stass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="2088" to="2095" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">affy-analysis of Affymetrix GeneChip data at the probe level</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gautier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Bolstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Irizarry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="307" to="315" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Converting cancer therapies into cures: lessons from infectious diseases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Glickman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Sawyers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="1089" to="1098" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Studies of thymocytopoiesis in rats and mice I Kinetics of appearance of thymocytes using a direct intrathymic adoptive transfer assay for thymocyte precursors</title>
		<author>
			<persName><forename type="first">I</forename><surname>Goldschneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Komschlies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Greiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="1" to="17" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">IgH and TCR-gamma gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias</title>
		<author>
			<persName><forename type="first">M</forename><surname>Golemovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sucic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zadro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mrsic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mikulic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Labar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Rajic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Batinic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia Res</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="211" to="221" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/ retroviral vector expressing the green fluorescence protein</title>
		<author>
			<persName><forename type="first">F</forename><surname>Grignani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kinsella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mencarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Valtieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Riganelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lanfrancone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Peschle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Nolan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pelicci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="14" to="19" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL</title>
		<author>
			<persName><forename type="first">V</forename><surname>Grossmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Haferlach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weissmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schindela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Poetzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bellos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Haferlach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schnittger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kohlmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosom Cancer</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="410" to="422" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group</title>
		<author>
			<persName><forename type="first">T</forename><surname>Haferlach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kohlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wieczorek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Basso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Kronnie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Bene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Gilkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiaretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shurtleff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kipps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Rassenti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Z</forename><surname>Yeoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Papenhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2529" to="2537" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kiladjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al-Ali</forename><surname>Hk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gisslinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Waltzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Stalbovskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcquitty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Knoops</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cervantes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Vannucchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barbui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Barosi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="787" to="798" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics</title>
		<author>
			<persName><forename type="first">J</forename><surname>How</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sykes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Minden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Yee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Schimmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Schuh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kamel-Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brandwein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Cancer J</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e116</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Huntly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shigematsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Deguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Duclos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Amaral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Curley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Akashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Gilliland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="587" to="596" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based model</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kawamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Katsura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">238</biblScope>
			<biblScope unit="page" from="23" to="36" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Outcome of biphenotypic acute leukemia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Killick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Matutes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Powles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamblin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Swansbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Treleaven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Atra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Catovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="699" to="706" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Koh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bezzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">X</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Teo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Gay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Al-Haddawi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Amati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Wee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guccione</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">526</biblScope>
			<biblScope unit="page" from="96" to="100" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Determinants of lymphoid-myeloid lineage diversification</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Laiosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stadtfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Graf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="705" to="738" />
			<date type="published" when="2006">2006a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU1 transcription factors</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Laiosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stadtfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Andres-Aguayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Graf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="731" to="744" />
			<date type="published" when="2006">2006b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia A microarray analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Larramendy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Niini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Elonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ollila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vihinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Knuutila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="569" to="577" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Goldschneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="607" to="622" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Transcriptional amplification in tumor cells with elevated c-Myc</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Loven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Rahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Paranal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Burge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bradner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Young</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="56" to="67" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia</title>
		<author>
			<persName><forename type="first">V</forename><surname>Liso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Specchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pannunzio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mestice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Palumbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Biondi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="471" to="473" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">) c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations</title>
		<author>
			<persName><forename type="first">H</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Neal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kreisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Beau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Tomasson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="2452" to="2461" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Dysregulated gene expression networks in human acute myelogenous leukemia stem cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Majeti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Weissman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="3396" to="3401" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Definition of acute biphenotypic leukemia</title>
		<author>
			<persName><forename type="first">E</forename><surname>Matutes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Farahat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Carbonell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Swansbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Catovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="64" to="66" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mayle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chang</forename><forename type="middle">E</forename><surname>Curry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Challen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wheeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Goodell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="629" to="638" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">In Vivo RNAi screening identifies a leukemiaspecific dependence on integrin beta 3 signaling</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Al-Shahrour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hartwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jaras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Puram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Puissant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Callahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ashton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Mcconkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Poveromo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Cowley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Kharas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Labelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shterental</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fujisaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Silberstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Alexe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al-Hajj</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Shelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="45" to="58" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Transcriptional priming of intrathymic precursors for dendritic cell development</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sarmiento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mohtashami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Braunstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Zuniga-Pflucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Development</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="373" to="384" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gokbuget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schlee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Benlasfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Farhadi-Sartangi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Thibaut</forename><forename type="middle">J</forename><surname>Burmeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hoelzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations</title>
		<author>
			<persName><forename type="first">E</forename><surname>Thiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Baldusn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Cancer J</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">e55</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">FLT3 mutations in early T-cell precursor all characterize a stem cell like leukemia and Imply the clinical use of tyrosine kinase inhibitors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Coskun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fransecky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Mochmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bartram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Sartangi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gokbuget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brandts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schlee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Duhrsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Griesshammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dohner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ehninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Burmeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Blau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hoelzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e53190</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Nie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yamane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Resch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tessarollo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Casellas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Levens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="68" to="79" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth</title>
		<author>
			<persName><forename type="first">T</forename><surname>Palomero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Odom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Sulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Real</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Margolin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Neil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Neuberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Aster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Sigaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Soulier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Look</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Califano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ferrando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="18261" to="18266" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ravandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paladugu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Barkoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Medeiros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Luthra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="35" to="45" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">A language and environment for statistical computing</title>
		<author>
			<persName><surname>R Core Team</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">R Foundation for Statistical Computing</title>
				<meeting><address><addrLine>Vienna, Austria</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">In vitro assays misrepresent in vivo lineage potentials of murine lymphoid progenitors</title>
		<author>
			<persName><forename type="first">Richie</forename><surname>Ehrlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Serwold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Weissman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="2618" to="2624" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Identification of T-lymphocytic leukemiainitiating stem cells residing in a small subset of patients with acute myeloid leukemic disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Risueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dingwall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levadoux-Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Leber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xenocostas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bhatia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="7112" to="7120" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU1</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rosenbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kutok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Iwasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Beau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Okuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Akashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fiering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="624" to="630" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU1</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rosenbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Tumang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Steidl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kutok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Clayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scheller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Iwasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hackanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Akashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Rothstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Plass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Tenen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="27" to="37" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Transcription factors in myeloid development: balancing differentiation with transformation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rosenbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Tenen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="105" to="117" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Launching the T-cell-lineage developmental programme</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Rothenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Yui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="9" to="21" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Transcriptional drivers of the T-cell lineage program</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Rothenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="132" to="138" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Kress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pelizzola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De Pretis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gorski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Morelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verrecchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Faga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ronchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guccione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Campaner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Amati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">511</biblScope>
			<biblScope unit="page" from="488" to="492" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Notch signaling controls the generation and differentiation of early T lineage progenitors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sambandam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Maillard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Zediak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Gerstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Aster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Pear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhandoola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="663" to="670" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Schlenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Madan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Laufle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Blum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Fehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Rodewald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="426" to="436" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment</title>
		<author>
			<persName><forename type="first">J</forename><surname>Schonheit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Gebhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Klett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Riemke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scheller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Naumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stocking</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Priller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Andrade-Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rosenbauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1617" to="1628" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Futreal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Erber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Mcmullin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Warren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Gilliland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Lodish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="page" from="459" to="468" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">shRNA screening identifies JMJD1C as being required for leukemia maintenance</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sroczynska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Cruickshank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Bukowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Miyagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">O</forename><surname>Bagger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walfridsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Schuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Porse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Helin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="1870" to="1882" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Lineage switch in acute leukemia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Stass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mirro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Melvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Pui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="701" to="706" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">The Authors The EMBO Journal</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Identification of COX17 as a therapeutic target for non-small cell lung cancer</title>
		<author>
			<persName><forename type="first">C</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Daigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Katagiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="7038" to="7041" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Treanor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Janke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Churchman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Mullighan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Sorrentino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="701" to="713" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Activating FLT3 mutations in CD4+/CD8-pediatric T-cell acute lymphoblastic leukemias</title>
		<author>
			<persName><forename type="first">P</forename><surname>Van Vlierberghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Meijerink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Stam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Van Der Smissen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Van Wering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Beverloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pieters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="4414" to="4415" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Van Vlierberghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ambesi-Impiombato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Keersmaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paietta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tallman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Forne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ferrando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia</title>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="74" to="82" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Verhaak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Wouters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Erpelinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Beverloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lugthart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lowenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Delwel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Valk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="131" to="134" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Adult T-cell progenitors retain myeloid potential</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Satoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kakugawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Katsura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">452</biblScope>
			<biblScope unit="page" from="768" to="772" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Acute myeloid leukemia stem cells and CD33-targeted immunotherapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Appelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Estey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Bernstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="6198" to="6208" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Mixed-phenotype acute leukemia: historical overview and a new definition</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">K</forename><surname>Weinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Arber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1844" to="1851" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">) c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Millholland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yashiro-Ohtani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Arcangeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Bianco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Sai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tobias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Shachaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Felsher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Blacklow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Pear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2096" to="2109" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Holmfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Heatley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Payne-Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rusch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Collins-Underwood</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">The genetic basis of early T-cell precursor acute lymphoblastic leukaemia</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Pounds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ulyanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Becksfort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gupta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">481</biblScope>
			<biblScope unit="page" from="157" to="163" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
